MASSAI, LARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.586
EU - Europa 2.472
AS - Asia 549
AF - Africa 12
OC - Oceania 6
SA - Sud America 5
Totale 5.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.578
PL - Polonia 856
RU - Federazione Russa 741
IT - Italia 319
IE - Irlanda 206
CN - Cina 170
HK - Hong Kong 144
SE - Svezia 133
SG - Singapore 128
DE - Germania 55
GB - Regno Unito 49
IN - India 37
FI - Finlandia 35
JO - Giordania 29
BE - Belgio 14
ES - Italia 13
FR - Francia 13
UA - Ucraina 13
CI - Costa d'Avorio 12
VN - Vietnam 12
CA - Canada 8
IL - Israele 8
CH - Svizzera 7
AT - Austria 6
JP - Giappone 6
NL - Olanda 6
AU - Australia 5
IR - Iran 5
BG - Bulgaria 3
BR - Brasile 3
TW - Taiwan 3
CO - Colombia 2
CZ - Repubblica Ceca 2
KR - Corea 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
Totale 5.630
Salva come PNG Salva come JPEG
Città #
Warsaw 856
Fairfield 430
Ashburn 234
Woodbridge 229
Chandler 219
Dublin 205
Houston 174
Seattle 165
Cambridge 159
Florence 139
Wilmington 132
Ann Arbor 120
Singapore 99
Hong Kong 97
Lawrence 77
Beijing 72
Altamura 71
Princeton 64
Buffalo 52
Boston 37
Shanghai 29
New York 28
Medford 27
Mumbai 26
San Diego 21
Moscow 19
Boardman 17
Brussels 14
Santa Clara 14
Abidjan 12
Barcelona 12
Kent 12
Bristol 11
Jacksonville 11
Los Angeles 10
West Jordan 10
Dong Ket 8
London 8
Norwalk 8
Pistoia 8
Bologna 7
Redwood City 7
Washington 7
Bern 6
Bremen 6
Falls Church 6
Frankfurt am Main 6
Phoenix 6
Toronto 6
Vienna 6
Wuhan 6
Canberra 5
Rehovot 5
Cagliari 4
Groningen 4
Hillsboro 4
Serra 4
Verona 4
Empoli 3
Fuzhou 3
Gainesville 3
Greenville 3
Göttingen 3
Hangzhou 3
Helsinki 3
Lappeenranta 3
Livorno 3
New Delhi 3
Prato 3
Pune 3
Redmond 3
Savannah 3
Shenzhen 3
Sofia 3
Taipei 3
Tel Aviv 3
Bogotá 2
Castelraimondo 2
Chengdu 2
Cleveland 2
Dearborn 2
Esslingen am Neckar 2
Glasgow 2
Gothenburg 2
Guangzhou 2
Kensington 2
Laurel 2
Madison 2
Milan 2
Montespertoli 2
Montpellier 2
Nanjing 2
Napoli 2
Olomouc 2
Reading 2
Reggio Emilia 2
Romainville 2
Romola 2
São Paulo 2
Tokyo 2
Totale 4.137
Salva come PNG Salva come JPEG
Nome #
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 241
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 234
Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration 227
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 225
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 224
Gold Compounds as Anticancer Agents: A Systematic Study of Gold–Protein Metalation 195
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 173
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 145
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 143
Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents 135
Bioconjugations of proteins with 19F and nitroxide tags for in vitro and in cell characterization 124
Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation 123
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 122
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 120
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 117
[Au(9-methylcaffein-8-ylidene)2]+/DNA Tel23 System: Solution, Computational, and Biological Studies 112
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 110
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 104
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles 104
The mode of action of anticancer gold-based drugs: a structural perspective 101
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 100
The cisplatin/serum albumin system: A reappraisal 93
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 91
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 89
Cisplatin binding to human serum albumin: a structural study 89
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 88
Size dependent biological profiles of PEGylated gold nanorods 84
Au2phen and Auoxo6, Two Dinuclear Oxo-Bridged Gold({III}) Compounds, Induce Apoptotic Signaling in Human Ovarian A2780 Cancer Cells 82
Anticancer Ruthenium(III) Complex KP1019 Interferes with ATP-Dependent Ca(2+) Translocation by Sarco-Endoplasmic Reticulum Ca(2+) -ATPase (SERCA) 80
Inhibition of Na+/K+-ATPase and cytotoxicity of a few selected gold(III) complexes 79
Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound 78
Interactions of selected gold(III) complexes with DNA G quadruplexes 77
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 76
Cell and Cell-Free Mechanistic Studies on Two Gold(III) Complexes with Proven Antitumor Properties 74
null 68
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 68
Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents 67
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 66
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 63
Selected Cytotoxic Gold Compounds cause Significant Inhibition of 20S Proteasome Catalytic Activities 62
Protonation of cyclen-based chelating agents containing fluorescent moieties 60
Bioconjugation of the gold drug auranofin to human ferritin yields a potent cytotoxin 55
Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes 53
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 53
Direct detection of iron clusters in L ferritins through ESI-MS experiments 52
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme 51
Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods 51
Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds 49
Pyrene-Containing Polyamines as Fluorescent Receptors for Recognition of PFOA in Aqueous Media 44
NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: Evidence for glutathione dysregulation 44
Mechanistic studies on cytotoxic gold compounds 42
Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System 41
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 41
Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1 40
Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs 39
Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications 39
Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs 38
19F: A small probe for a giant protein 37
The effects of two cytotoxic gold(i) carbene compounds on the metabolism of A2780 ovarian cancer cells: mechanistic inferences through NMR analysis 36
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme 36
The effects of two gold-N-heterocyclic carbene (NHC) complexes in ovarian cancer cells: a redox proteomic study 32
null 31
Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments 29
Na/K-ATPase as a target for anticancer metal based drugs: insights into molecular interactions with selected gold(iii) complexes 29
Mercury binding to proteins disclosed by ESI MS experiments: The case of three organomercurials 27
Large Protein Assemblies for High-Relaxivity Contrast Agents: The Case of Gadolinium-Labeled Asparaginase 26
null 21
null 18
Totale 5.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020894 0 0 0 74 130 120 112 131 111 80 109 27
2020/2021569 43 69 15 71 25 56 27 40 53 107 32 31
2021/2022436 16 37 28 16 17 23 13 35 25 24 88 114
2022/2023983 97 219 65 70 57 166 127 43 91 10 23 15
2023/2024574 19 38 74 23 34 62 33 119 15 35 75 47
2024/20251.050 133 326 211 380 0 0 0 0 0 0 0 0
Totale 5.767